Xininurad is a potent orally active URAT1 inhibitor with an IC50 of 7.17 nM. Xininurad inhibits URAT1 activity to reduce serum uric acid levels and increase urinary uric acid excretion. Xininurad can be used for the research of hyperuricemia and gout[1].
Molecular Weight:
443.07
Purity:
99.59
CAS Number:
[2365178-28-3]
Formula:
C15H10Br2FN3O2
Target:
URAT1
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted